Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (2868)	10/25/2011 10:25:39 AM
From: idos	Read Replies (3) of 3027

Well, I don't think anyone including Amphastar was expecting the FDA approval in Sep so Sanofi's timing of launching its AG is another surprise. My view on this timing is similar to Peter's ( siliconinvestor.com ): that they were preparing for a launch since Sep and probably got a legal opinion from their patent lawyers on the odds for PI that favored a quick launch. On the implication on possible injunction, I agree with ij ( siliconinvestor.com ): that MNTA's irreparable harm argument has been damaged by the launch of AG. I don't know what Sanofi will do if MNTA gets its PI, perhaps play with pricing?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next